VYOME HOLDINGS, INC. Proceeds from Issuance of Convertible Preferred Stock
VYOME HOLDINGS, INC. (HIND) reported Proceeds from Issuance of Convertible Preferred Stock of $191.25 thousand for the 6-month period ending 2025-06-30, per its 8-K filed 2025-09-02.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock · last filed 2025-09-02
- 2025-06-30: Proceeds from Issuance of Convertible Preferred Stock 6 month $191.25K.
- 2024-06-30: Proceeds from Issuance of Convertible Preferred Stock 6 month $340.00K.
| Period end | Proceeds from Issuance of Convertible Preferred Stock 6 month |
|---|---|
| 2025-06-30 | $191.25K 8-K · filed 2025-09-02 |
| 2024-06-30 | $340.00K 8-K · filed 2025-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |